Loblaw ready for lower drug prices

Article Excerpt

LOBLAW COMPANIES LTD. $65 (Toronto symbol L; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 395.3 million; Market cap: $25.7 billion; Price-to-sales ratio: 0.5; Dividend yield: 1.7%; TSINetwork Rating: Above Average; www.loblaw.ca) operates 1,095 supermarkets across Canada. It also owns the Shoppers Drug Mart chain of 1,330 drugstores. The company faces several challenges in 2018. Those include higher minimum wages in Ontario, Alberta and other provinces. In addition, a new deal between government health agencies and pharmaceutical makers will cut the selling prices of generic drugs, and squeeze the profit margins at its drugstores. Loblaw plans to offset some of those costs with new initiatives such as installing more automated checkout stations. The merger of its supermarket and Shoppers Drug Mart loyalty points plans should also cut its expenses. The company will probably earn $4.75 a share in 2018. The stock trades at an attractive 13.7 times that forecast. The $1.08 dividend yields 1.7%. Loblaw is a buy. buy…